BDBM163042 US9062004, 5::US9670216, 13 4-Bromo-5-propylamino-2-(3,3,5,5-tetramethylcyclohexyl)pyridazin-3-one

SMILES CCCNc1cnn(C2CC(C)(C)CC(C)(C)C2)c(=O)c1Cl

InChI Key InChIKey=YMCXJOJJPKTDCH-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 163042   

TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  1.02E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  5.40nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  4.80nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  5.40nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  174nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  1.02E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent